Advertisement
Screener

Lunai Bioworks Inc. (LNAI) Form D

Lunai Bioworks Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2024-02-23: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2024-02-13; Total offering amount $106,849,547.
  • 2016-09-15: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale Yet to occur; Total offering amount $16,500,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2024-02-23Rule 506(b)Equity2024-02-13$106,849,547$106,849,547$08
2016-09-15Rule 506(b)EquityYet to occur$16,500,000$0$16,500,0000

Similar stocks

Stock NameCountryMarket CapPE Ratio
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Cingulate Inc. (CING)United States$0.073B-2.64
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
OS Therapies Inc (OSTX)United States$0.076B-2.17
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39